Metascreen^® is a simple and non-invasive urine test to screen more than 100 metabolic disorders without causing any harm or discomfort to the baby. Metascreen^® uses a gas-chromatography mass spectrometry (GC-MS) technology manufactured by Shimadzu, Japan.

This genetic screening test can accurately identify the early onset of 117 disorders that are associated with symptoms such as autism and ADHD by analyzing more than 250,000 chromosome regions.